The National Institute of Allergy and Infectious Diseases has started a series of clinical trials on humans to examine a potential vaccine candidate NIAID hopes can help counter the Zika virus. NIAID started the trials to evaluate how the vaccine creates an immune system response in more than 80 healthy volunteers that will participate in the trials …